Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;89:744-746

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dzeja, P. P.
Right arrow Articles by Terzic, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dzeja, P. P.
Right arrow Articles by Terzic, A.
(Circulation Research. 2001;89:744.)
© 2001 American Heart Association, Inc.


Editorials

Mitochondria

Gateway for Cytoprotection

Petras P. Dzeja, Ekshon L. Holmuhamedov, Cevher Ozcan, Darko Pucar, Arshad Jahangir, Andre Terzic

From the Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Mayo Foundation, Rochester, Minn.

Correspondence to Andre Terzic, Guggenheim 7, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. E-mail terzic.andre@mayo.edu


Key Words: cardioprotection • energetics • metabolic signaling • potassium channel openers • heart

Tissues with high-energy turnover, such as heart muscle, heavily depend on ATP produced by mitochondrial oxidative phosphorylation, and therefore display particular vulnerability to insults induced by deprivation of oxygen and/or metabolic substrates.1,2 Along with oxidative phosphorylation, mitochondria are central in regulating Ca2+ signaling, free radical production, and release of apoptosis-inducing factors.3–7 Through dynamic feedback communication, mitochondrial functions are tightly integrated with cellular processes securing ionic and energetic homeostasis.2,8 In particular, phosphotransfer relays have emerged as mechanisms responsible for efficient coupling of mitochondrial ATP production with cellular sites of ATP utilization and/or ATP sensing.9–12 In this way, mitochondria can orchestrate vital processes throughout the cell, ultimately supporting cellular life and determining cell longevity.4,6,13 In fact, mitochondrial dysfunction disrupts cellular energy metabolism precipitating progression of degenerative disease states.13,14 Thus, preservation of mitochondria and associated energetic pathways has paramount significance in the ability of cardiomyocytes to withstand metabolic injury. Yet, little is known about mechanisms that would enhance mitochondrial tolerance to stress and induce cellular protection.

Recently, it has become apparent that mitochondria harbor sufficient functional plasticity to respond to metabolic challenge.15 By virtue of their ability to generate and accommodate stress-induced signals, mitochondria could serve as triggers and/or end-effectors in the cycle of events protecting mitochondrial integrity, transfer, and utilization of ATP and ultimately cell survival.2,7,13–17 Such new developments in our understanding of mitochondrial biology provide an exciting opportunity in enhancing cellular tolerance to stress by exploiting mitochondria-mediated cytoprotection.17

Several strategies that directly modulate mitochondrial respiration, ATP production, ion transport, cytochrome c . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Circ. Res.Home page
R. F. Kelly, W. Sluiter, and E. O. McFalls
Hibernating Myocardium: Is the Program to Survive a Pathway to Failure?
Circ. Res., January 4, 2008; 102(1): 3 - 5.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Mayevsky and G. G. Rogatsky
Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C615 - C640.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Henle, J. Leemhuis, C. Fischer, H. H. Bock, K. Lindemeyer, T. J. Feuerstein, and D. K. Meyer
Gabapentin-Lactam Induces Dendritic Filopodia and Motility in Cultured Hippocampal Neurons
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 181 - 191.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H.-S. Sun, Z.-P. Feng, T. Miki, S. Seino, and R. J. French
Enhanced Neuronal Damage After Ischemic Insults in Mice Lacking Kir6.2-Containing ATP-Sensitive K+ Channels
J Neurophysiol, April 1, 2006; 95(4): 2590 - 2601.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Ishii, S. Ichimiya, M. Kanashiro, T. Amano, T. Matsubara, and T. Murohara
Effects of Intravenous Nicorandil Before Reperfusion for Acute Myocardial Infarction in Patients With Stress Hyperglycemia
Diabetes Care, February 1, 2006; 29(2): 202 - 206.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. M. Ludwig, K. Tanaka, J. T. Eells, D. Weihrauch, P. S. Pagel, J. R. Kersten, and D. C. Warltier
Preconditioning by Isoflurane Is Mediated by Reactive Oxygen Species Generated from Mitochondrial Electron Transport Chain Complex III
Anesth. Analg., November 1, 2004; 99(5): 1308 - 1315.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Minners, C. J. McLeod, and M. N. Sack
Mitochondrial plasticity in classical ischemic preconditioning--moving beyond the mitochondrial KATP channel
Cardiovasc Res, July 1, 2003; 59(1): 1 - 6.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-M. Cha, P. P. Dzeja, W. K. Shen, A. Jahangir, C. Y. T. Hart, A. Terzic, and M. M. Redfield
Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability
Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1313 - H1320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. P. Dzeja, P. Bast, C. Ozcan, A. Valverde, E. L. Holmuhamedov, D. G. L. Van Wylen, and A. Terzic
Targeting nucleotide-requiring enzymes: implications for diazoxide-induced cardioprotection
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1048 - H1056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Nowak
Protein Kinase C-alpha and ERK1/2 Mediate Mitochondrial Dysfunction, Decreases in Active Na+ Transport, and Cisplatin-induced Apoptosis in Renal Cells
J. Biol. Chem., November 1, 2002; 277(45): 43377 - 43388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Pucar, P. Bast, R. J. Gumina, L. Lim, C. Drahl, N. Juranic, S. Macura, E. Janssen, B. Wieringa, A. Terzic, et al.
Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H776 - H782.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. P. Dzeja, R. Bortolon, C. Perez-Terzic, E. L. Holmuhamedov, and A. Terzic
Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer
PNAS, July 23, 2002; 99(15): 10156 - 10161.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. HOLMUHAMEDOV, L. LEWIS, M. BIENENGRAEBER, M. HOLMUHAMEDOVA, A. JAHANGIR, and A. TERZIC
Suppression of human tumor cell proliferation through mitochondrial targeting
FASEB J, July 1, 2002; 16(9): 1010 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Ozcan, M. Bienengraeber, P. P. Dzeja, and A. Terzic
Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H531 - H539.
[Abstract] [Full Text] [PDF]